Thyroglobulin gene expression was repressed in a rat thyroid cell line transformed with Kirsten murine sarcoma virus. Expression of a dominant selectable marker driven by the thyroglobulin promoter was also inhibited. Somatic cell hybridization of transformed and differentiated thyroid cells resulted in extinction of thyroglobulin gene expression. When transformed cells carrying a dominant selectable marker driven by the thyroglobulin promoter were fused to differentiated cells and expression of this marker was selected, we obtained stable hybrid cell lines expressing both the endogenous and the exogenous thyroglobulin promoters. Although the expression of v-ras remained unchanged compared with expression in the parental transformed cells, transformation was suppressed in the hybrid cell lines. The other thyroid differentiation markers, iodide uptake and thyroid-stimulating hormone-dependent growth, were inhibited in all the hybrids tested. We show that activity of the thyroglobulin promoter correlates with the presence of a thyroid nuclear factor that binds the promoter at position -60 from the transcription start site. Loss of this factor accompanies the extinction of thyroglobulin gene expression in hybrids selected for expression of a non-thyroid-specific promoter.
Thyroglobulin gene expression was repressed in a rat thyroid cell line transformed with Kirsten murine sarcoma virus. Expression of a dominant selectable marker driven by the thyroglobulin promoter was also inhibited. Somatic cell hybridization of transformed and differentiated thyroid cells resulted in extinction of thyroglobulin gene expression. When transformed cells carrying a dominant selectable marker driven by the thyroglobulin promoter were fused to differentiated cells and expression of this marker was selected, we obtained stable hybrid cell lines expressing both the endogenous and the exogenous thyroglobulin promoters. Although the expression of v-ras remained unchanged compared with expression in the parental transformed cells, transformation was suppressed in the hybrid cell lines. The other thyroid differentiation markers, iodide uptake and thyroid-stimulating hormone-dependent growth, were inhibited in all the hybrids tested. We show that activity of the thyroglobulin promoter correlates with the presence of a thyroid nuclear factor that binds the promoter at position -60 from the transcription start site. Loss of this factor accompanies the extinction of thyroglobulin gene expression in hybrids selected for expression of a non-thyroid-specific promoter.
Studies on somatic cell hybrids have shown that (i) the fusion of a cell line that expresses a specific gene product with a nonexpressing cell line leads to extinction of the tissue-specific product in the stable hybrid (8, 13, 16, 23, 34) and (ii) the fusion of a normal with transformed cell frequently yields untransformed hybrids (12, 19, 31) . In both cases, the hybrid phenotypes (extinction and suppression of transformation) appear to be linked to specific genetic loci (termed extinguishers for the intertypic hybrids) (23) . This has been shown to be the case for many cell type-specific genes, including liver-specific genes (6, 8, 23, 30, 37) , and growth hormone expression (34) . Transformation suppressor genes have recently been isolated (15, 28) . The interaction of the proteins encoded by these genes with oncogene products is thought to play an essential role in determining transformation (22, 33, 36) .
Over the past several years, we have explored the mechanism by which transformation by Ki-ras suppresses the expression of thyroid-specific differentiation markers. We have used an established rat thyroid cell line that expresses three differentiation characteristics: thyroglobulin synthesis, iodide uptake, and thyroid-stimulating hormone (TSH)-dependent growth. The thyroglobulin gene (Tg) has been cloned, and the cis element required for thyroid-specific expression has been defined (29) . One element, located at -60 nucleotides from the transcription start site (site C), binds a factor (thyroglobulin transcription factor [TgTF1]) found only in the nuclear extracts of thyroid cells (29) . All three thyroid differentiation markers are lost after transformation with Kirsten murine sarcoma virus (KiMSV) (11, 18) . We have also demonstrated that the Tg promoter (pTg) in transformed cells can be activated after fusion with the parental cell line (2) . In heterokaryons, the nucleus of the differentiated cell presumably supplies a trans-acting factor(s) to the transformed nucleus. Transient activation in * Corresponding author.
heterokaryons has been documented also for globin genes (4) and muscle-specific genes (7) . Recently, we have provided evidence suggesting that v-ras inactivates the trans-acting factor, TgTF1. Loss of TgTF1 is subsequently imprinted by DNA methylation so that a functional v-ras is no longer required (3).
Here we report further experiments on the mechanism of suppression of Tg expression in transformed thyroid cells. Somatic cell hybridization of differentiated and transformed thyroid cells results in extinction of Tg expression and suppression of the transformed phenotype. When transformed cells carrying a dominant selectable marker driven by pTg are fused to differentiated cells and expression of this marker is selected, we obtain stable hybrid cell lines expressing pTg. The activity of pTg correlates with the presence of TgTF1. This factor cannot be detected in hybrids carrying an inactive pTg. These results suggest that TgTF1 is a positive regulator of pTg transcription and that inactivation of this factor accounts for the failure of Tg expression in hybrids of differentiated x transformed thyroid cells.
MATERIALS AND METHODS
Plasmids. pTg-CAT contains 800 base pairs (bp) of pTg fused to the chloramphenicol acetyltransferase (CAT) gene (20, 29) . pTg-NEO contains 3,500 bp of pTg fused to the aminoglycoside phosphotransferase gene (3, 32) . pTg-GPT contains 800 bp of pTg Escherichia coli fused to the guaninehypoxanthine phosphoribosyltransferase (GPT) gene (10) . The pTg fragment EcoRI-HindIII was derived from pTg-CAT (29) , and the E. coli GPT gene fragment HindIllBamHI was derived from pRSV-GPT (10, 20 (32) . KM-pTg-GPT designates a pool of 10 clones of KM transfected with pRSV-hygromycin pTg-GPT, and pTg-CAT. These clones were isolated from the original transfected population and analyzed by Southern blotting (35) for the presence of the three DNA markers.
KM-pRSV-HYG represents a pool of 20 clones of KM cells transfected with pRSV-hygromycin and pTg-CAT (ratio of 1:10) containing by Southern blot analysis 10 to 20 copies of pRSV-hygromycin and 5 to 10 copies on average of pTg-CAT DNA per haploid genome.
Transfections. All transfections were performed by the calcium phosphate technique (21) . The cotransfections were carried out by using a 1:10 ratio of neutral (pRSV-hygromycin and pRSV-NEO) to specific (pTg-CAT and pTg-GPT) markers. When three markers were combined in the cotransfections experiments, the ratio was 1:5:8 (pRSV-hygromycin/pTg-GPT/pTg-CAT). The efficiency of cotransfection for KM cells was around 70%. Cell fusion. Fusion between the different cell types was performed by using Sendai virus as described previously (2) . The cells were mixed at a 1:1 ratio (ca. 106 cells) and split in two samples; to one was added the virus, and the other was processed in the same way except that the virus was not added. Three days after the fusion, the cells were split and the selection was applied. GPT selection was performed in hypoxanthine-aminopterin-thymidine medium supplemented with mycophenolic acid (40 jig/ml) and xanthine (100 Lg/ml).
Neor selection was carried out at 400 ,ug of G418 per ml. Hygromycin selection was carried out in a medium (F-12 (25) .
Nuclear extracts and gel retardation assay. Nuclear extracts from the different cell lines were prepared essentially as described previously (38) . The concentration of nuclear proteins was around 2 to 5 ,ug/,ul. The DNA oligonucleotides used were from the -60 region of the pTg (oligonucleotide C, a generous gift from R. Di Lauro, European Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany). The DNA sequence is 5'-GCCACTGCCCAGTCAAGTGTTCT TGAA-3'. The DNA oligonucleotides were end labeled by T4 polynucleotide kinase (26) , and 50 fmol was incubated with 5 to 10 jig of nuclear proteins in the presence of 2 ,ug of poly (dI-dC) per ml, 5 mM spermidine in 10% glycerol, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9), 50 mM NaCl, and 0.1 mM phenylmethylsulfonyl fluoride in a final volume of 20 ,tl for 15 min at room temperature. The DNA-protein complexes were resolved by 6% polyacrylamide gel in 0.5x TBE buffer (17) . TL-KM hybrids, therefore, resembled the phenotype of intertypic hybrids described by several authors (23, 30, 31, 34) .
RESULTS

Extinction of
Somatic cell hybrids expressing Tg. The hybrids shown above failed to express Tg even though transformation was suppressed. In characterizing these clones, however, we were intrigued by the occasional finding of an unstable pTg-CAT activity; some clones might only partially extinguish thyroid markers. To isolate these clones, we decided to select directly for the expression of pTg during the formation and stabilization of the hybrids. We linked the GPT gene to a pTg fragment that extends 800 bp 5' to the thyroglobulin structural gene and contains the cis elements conferring thyroid-specific expression. The pTg-GPT fusion was cotransfected in KM cells with pRSV-NEO and pTg-CAT plasmids.
Three representative clones, KM1, KM4, and KM9, containing 5, 10, and 20 copies of pTg-GPT and 2, 6, and 10 copies of pTg-CAT, respectively, per haploid genome were tested for the GPT+ phenotype. The three clones were mycophenolic acid sensitive (GPT-), in contrast to thyroid TL cells carrying pTg-GPT DNA (see Materials and Methods), which efficiently expressed the GPT+ phenotype (Fig.  2B) . The frequency of GPT-phenotypic reversion to GPT+ in KM clones was around 1 x 10' to 5 x 10-4 (Fig. 2B) . The CAT activity of the three clones was 10-to 20-fold lower than that of the differentiated control cells (Fig. 2) . These data indicate that pTg-GPT and pTg-CAT fusions are transformation sensitive.
The three clones described above were pooled and fused with Sendai virus either to TL cells or to rat fibroblasts and subjected to GPT selection for 15 days. Figure 3A shows the number of GPT+ clones generated by the fusion of KM1, KM4, and KM9 either to thyroid cells (PC or TL) or to rat fibroblasts. Only fusions with differentiated thyroid cells (TL or PC) generated GPT+ clones. Fusion of KM1, KM4, and KM9 alone or with rat fibroblasts yielded GPT+ clones at a frequency at least 10-to 20-fold lower (Fig. 3A) .
The GPT+ clones appear to be hybrids between normal and transformed cells on the basis of the following criteria: (i) karyotype analysis ( We then analyzed the other thyroid differentiation markers in GPT+ clones. Iodide uptake, TSH-dependent growth, and TSH activation of adenyl cyclase were abolished. These cells failed to grow in semisolid medium, in contrast to the KM parental cells (Table 2) .
To determine whether the endogenous pTg was also active in the GPT+ clones, we assayed for the presence of Tg RNA by Northern blot analysis. RNA was isolated from the various cell lines and probed against rat Tg cDNA (27). Tg mRNA was evident in TL cells (Fig. 4A, lane 1) but not in KM cells either self-fused or unfused (Fig. 4A, lanes 5 and  6) . RNA extracted from three GPTI clones clearly included Tg mRNA (Fig. 4A, lanes 2 to 4) pool of KM containing pTg-GPT and pTg-CAT, described above (O), were plated in the presence of various concentrations of mycophenolic acid (Myc). After 15 days, the surviving clones were counted; the number is reported. Revertants of KM cells to GPT+ were isolated at a frequency of 10-4; none showed CAT activity. and GPTI cells. We also examined the rare spontaneous GPTI revertants of KM1, KM4, and KM9 cells. In these GPTI cells, Tg mRNA was undetectable (Fig. 4B, lane 3) , and no CAT activity was found (data not shown).
The expression of v-ras in GPT+ clones was comparable to that in the transformed parental KM cells. These GPT+ clones, grown without GPT selection, at high frequency lost the GPT' phenotype and reacquired the ability to grow in agar (Table 2) . Karyotype heterogeneity and chromosomal loss were noted in these clones (data not shown). One plausible explanation for this instability may be that no direct selection for the presence of the differentiated chromosome(s) was applied on these clones. To monitor the presence of normal chromosomes in hybrids between normal and transformed cells, we introduced an exogenous pTg linked to a dominant marker (pTg-NEO) in TL cells. The pTg-NEO DNA construct contains a 3,500-bp fragment of pTg linked to the neomycin resistance gene; the fragment contains all of the cis elements conferring thyroid-specific expression (29) . TL cells carrying a pTg-NEO fusion were hybridized to KM cells carrying pRSV-HYG and pTg-CAT DNAs, and Hyg+ Neo+ cells were selected. The phenotypes of these hybrids are shown in Table 3 (class II). The thyroid differentiation markers, iodide uptake and TSH response, were inactive. pTg-CAT was functional in 90% of the clones, and endogenous Tg transcription was detectable (Fig. 4B,  lane 4) . Neomycin resistance gene and CAT mRNAs were transcribed from pTg, as demonstrated by RNase mapping of the 5' end of the transcripts (data not shown). In conclusion, Hyg+ Neo+ hybrids had a phenotype identical to that of the GPT+ clones (Table 3 ). These data indicate that TL cells in TL-KM hybrids provide a trans-acting factor(s) that activates pTg-CAT or pTg-GPT in KM cells. The specific selection for pTg expression allows the detection and isolation of cells expressing both endogenous and exogenous pTg.
Activation of pTg correlates with the presence of a thyroidspecific trans-acting factor present in the hybrids expressing Tg. It was found that Tg expression could escape extinction in somatic hybrids and that this phenomenon was mediated by a thyroid-specific function (Fig. 3A) .
TgTF1 is a thyroid-specific trans-acting factor that binds Tg at -60 from the transcription start site and disappears in v-ras-transformed thyroid cells (2, 3) . We therefore asked whether this specific trans-acting factor correlated with Tg expression in the selected hybrids. Using a specific oligonucleotide from the -60 region of pTg, we analyzed by gel retardation assay the activity of TgTF1 in the hybrids expressing pTg-CAT. The specific DNA-protein complex formed between the DNA oligonucleotide spanning the -60 region was (i) thyroid specific, since it was present in normal thyroid cells (TL in Fig. 5A ) but absent in nuclear extracts from liver and fibroblasts, and (ii) transformation sensitive, since it was absent in KM transformed cells or in KM-KM hybrids. Also, TgTF1 was present in GPT+ hybrids (H1) and hybrids derived from the fusion pRSV-HYG-pTg-NEO (H2 and H3). Both of these hybrids expressed exogenous and the endogenous pTg. TgTF1 isolated from TL and Hi or H3 cells could not be distinguished biochemically. In addition to forming oligonucleotide complexes with identical gel mobilities, both factors made the same DNA contact points, as revealed by DNA dimethyl sulfate protection patterns (data not shown), ruling out the possibility that cell fusion activated a new trans-acting protein binding pTg. We asked next whether TgTF1 was present in hybrids carrying an inactive pTg. Figure 6A shows the gel retardation analysis of the nuclear cell extracts of hybrids formed by selection (pRSV-HYG-pRSV-NEO). The binding activity at the -60 region of pTg was completely absent in four isolated clones derived from these hybrids.
In addition to the DNA-protein complex at the -60 region, we have identified a second pTg-linked site (site A) in the -150 region of pTg that binds a non-thyroid-specific transacting factor (factor A) that is present in the nuclear extracts of all cell lines tested (35a; D. Civitareale, R. Lonigro, A. Sinclair, and R. Di Lauro, EMBO J., in press). The specific complex formed with a DNA oligonucleotide corresponding to the -150 region was present in the hybrids as well as in the parental cells (Fig. 6B) .
These data suggest that the trans-activation of pTg in the transformed cells after hybridization with normal thyroid cells may be mediated by the thyroid-specific trans-acting factor TgTF1 and that inactivation of this factor may account for the absence of Tg expression in neutral hybrids. DISCUSSION Suppression of transformed phenotype in hybrid differentiated x transformed thyroid cells. In all hybrids between differentiated and transformed cells described in this report, the transformed phenotype is recessive regardless of the cell partners used in the fusion or the specific promoter selection imposed on hybrid cells (Tables 1 to 3 ). The suppression of transformation is reversible, since we can isolate from the hybrid population transformed revertants at high frequency (Table 2 ). In addition v-ras transcription is not affected by cell hybridization. These data indicate that v-ras in the hybrid cell lines, even though the transformed phenotype is -inhibited, retains its transforming potential. Fig. 4 and Table 2 ; KM KM represents the nuclear extract from the heterokaryons between KM and KM; KM and TL represent the nuclear extracts from KM1 and TL-pTg-NEO cells, respectively. The amount of extract per assay was 10 ,ug of nuclear protein. Lanes F and L are the nuclear extracts from rat fibroblasts (Rat 2) and rat liver, respectively; H2 and H3 represent the nuclear extracts derived from two clones obtained from the fusion of KM-pRSV-HYG and TL-pTg-NEO cells (class II; Table 3 ).
Recently, several transformation suppressor genes have been cloned and identified (15, 28 transcriptional block of the growth hormone-specific transactivator gene (27) . The 
